Transcatheter aortic valve replacement: The year in review 2017
暂无分享,去创建一个
[1] K. Harjai,et al. Suitability for Watchman Implantation in TAVR Patients with Atrial Fibrillation , 2018 .
[2] V. Rigolin,et al. 2017 Focused Update for Management of Patients With Valvular Heart Disease: Summary of New Recommendations , 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.
[3] J. Leipsic,et al. Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Stenosis. , 2017, Journal of the American College of Cardiology.
[4] Jeroen J. Bax,et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. , 2017, Journal of the American College of Cardiology.
[5] J. Rumsfeld,et al. Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation. , 2017, The Annals of thoracic surgery.
[6] S. Windecker,et al. Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney Disease. , 2017, The American journal of cardiology.
[7] Prashanth,et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement , 2017 .
[8] J. Leipsic,et al. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve , 2017, JAMA cardiology.
[9] L. Svensson,et al. Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis , 2017, Journal of the American Heart Association.
[10] J. Harnek,et al. Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[11] S. Windecker,et al. Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study. , 2017, Journal of the American College of Cardiology.
[12] J. Leipsic,et al. CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. , 2017, JACC. Cardiovascular interventions.
[13] I. Palacios,et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. , 2017, Journal of the American College of Cardiology.
[14] Sean M. O'Brien,et al. Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison. , 2017, Journal of the American College of Cardiology.
[15] J. Harnek,et al. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort). , 2017, The American journal of cardiology.
[16] J. Webb,et al. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. , 2017, JACC. Cardiovascular interventions.
[17] Eugene Blackstone,et al. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes: The STS/ACC TVT Registry. , 2017, Journal of the American College of Cardiology.
[18] N. Weissman,et al. Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis , 2017, Circulation. Cardiovascular imaging.
[19] Wen Cheng,et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study , 2017, The Lancet.
[20] S. Kohsaka,et al. Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement , 2017, Circulation.
[21] M. Deutsch,et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. , 2017, JACC. Cardiovascular interventions.
[22] J. Leipsic,et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. , 2017, Journal of the American College of Cardiology.
[23] N. Moat,et al. One-Year Outcomes of Transcatheter Aortic Valve Implantation Using the Direct Aortic Approach. , 2017, The Annals of thoracic surgery.
[24] F. Spencer,et al. Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis , 2017, Stroke.
[25] D. Adams,et al. One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. , 2017, The Annals of thoracic surgery.
[26] J. Leipsic,et al. Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. , 2017, JACC. Cardiovascular interventions.
[27] D. Berman,et al. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. , 2017, JACC. Cardiovascular imaging.
[28] G. Richardt,et al. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. , 2017, JACC. Cardiovascular interventions.
[29] P. Jüni,et al. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[30] T. Walther,et al. Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID) , 2017, Circulation. Cardiovascular interventions.
[31] F. Neumann,et al. SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. , 2017, Circulation.
[32] Jeroen J. Bax,et al. Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. , 2017, Journal of the American College of Cardiology.
[33] Andrew S. Mugglin,et al. Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.
[34] G. Deeb,et al. Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. , 2017, JACC. Cardiovascular interventions.
[35] W. O’Neill,et al. Transcaval Access and Closure for Transcatheter Aortic Valve Replacement: A Prospective Investigation. , 2017, Journal of the American College of Cardiology.
[36] K. Harjai,et al. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement , 2017, Journal of the American Heart Association.
[37] G. Perlman,et al. Electrocardiographic Predictors of Long‐Term Cardiac Pacing Dependency Following Transcatheter Aortic Valve Implantation , 2017, Journal of cardiovascular electrophysiology.
[38] R. Virmani,et al. Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. , 2017, Journal of the American College of Cardiology.
[39] S. Nakatani,et al. Clinical Outcomes and Bioprosthetic Valve Function After Transcatheter Aortic Valve Implantation Under Dual Antiplatelet Therapy vs. Aspirin Alone. , 2017, Circulation journal : official journal of the Japanese Circulation Society.
[40] M. Zembala,et al. Improvement of quality of life following transcatheter aortic valve implantation in the elderly: a multi-centre study based on the Polish national TAVI registry. , 2017, Kardiologia polska.
[41] J. Popma,et al. Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis. , 2017, JACC. Cardiovascular interventions.
[42] K. Takagi,et al. Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding , 2016, Heart.
[43] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[44] S. Blankenberg,et al. Transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses. , 2017, Interactive cardiovascular and thoracic surgery.